Protein Engineering Market Insights :
Protein Engineering Market is projected to be worth USD 9.39 Billion by 2030, registering a CAGR of 12.7% during the forecast period (2022-2030), The market was valued at USD 3.20 Billion in 2021. Instruments were the largest product sector in this market owing to technical improvements and expensive mass spectroscopy and crystallography devices. The growing need for monoclonal antibodies for the treatment of cancer, neurological illnesses, and infectious diseases is responsible for the growth of the segment. North America will have a significant market share in 2021 in the protein engineering market.
Protein Engineering Market Dynamics:
Protein engineering is a technique of shifting a protein sequence to achieve an ideal result, such as improved constancy to the temperature, shift in the substrate specificity organic solvents, and extremes of PH. Protein engineering is divided into various protein types such as erythropoietin, coagulation factors, monoclonal antibodies, vaccines, interferons, growth hormones, colony-stimulating, and others.
Driver:
The rising inclination for protein therapeutics over non-protein drugs is a primary driver of the market. Further, the increasing positive outcome of clinical research is fueling the growth of the protein engineering market.
Restraint:
Stringent regulation and high investment in clinical research, expensive tools are the factors expected to hamper the growth of the protein engineering market.
Opportunity:
Increasing adoption of tools and development of advanced therapeutics is anticipated to create lucrative opportunities for the protein engineering market. Moreover, increasing mergers and acquisition in the market is expected to create growth opportunities for the key players.
COVID-19 Analysis of Protein Engineering Market:
The protein engineering market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the protein engineering market is moderate. Post covid-19 there was a positive impact on the protein engineering Market as consumers were more focused on health, which increased the demand for protein engineering.
Cancer Immunotherapy Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 9.39 |
| CAGR (2022-2030) | 12.7% |
| By Product and Service | Instruments, Consumables, Software & Services |
| By Technology | Rational Protein Design, Irrational Protein Design |
| By Protein Type | Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-stimulating Factors, Growth Hormones, Coagulation Factors, Other |
| By End-Use | Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Agilent Technologies, Inc, Waters Corporation, Danaher Corporation, Codexis, Inc., New England Biolabs, Inc., PerkinElmer, Innovagen AB, GE Healthcare, CUSABIO TECHNOLOGY LLC, Promega Corporation, Merck KGaA, GenScript Biotech Corporation, Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical, Aspira Chemical, Zymeworks, Inc., Abzena, Ltd., PhyNexus, Inc., ProteoGenix, and Creative Biolabs.’ |
Protein Engineering Market Segment Analysis:
By Product and Service
The market is divided into three categories instruments, consumables, and software and services. Owing to technical improvements and expensive mass spectroscopy and crystallography devices, instruments were the largest product sector in this market. Extensive use of new technologies and process innovations in proteome research are major market drivers of the market. Further, mass spectrometry, gel electrophoresis, and computational prediction algorithms are among these technologies used as instruments. This enables quick identification, characterization of proteomes, and function determination, all of which are key features of protein engineering, driving the widespread use of instruments. These factors are expected to boost the growth of the protein engineering market.
By Protein Type
The protein type segment is divided into insulin, monoclonal antibodies, interferons, vaccines, erythropoietin, colony-stimulating factors, coagulation factors, growth hormones, and other proteins. In 2021, monoclonal antibodies held the biggest market share. The growing need for monoclonal antibodies for the treatment of cancer, neurological illnesses, and infectious diseases is responsible for the growth of the segment in the protein engineering market. Additionally, the rising demand for individualized medicine is also viewed as a high-impact driving factor for the segment’s growth throughout the forecast period. Furthermore, protein engineering confers several advantages, such as fewer unwanted effects and increased homogeneity and specificity of mAbs, which drives researchers’ preference for modeling mAbs to provide therapeutically better versions, which in turn drives the protein engineering market expansion.
By Technology
The market is divided into rational and irrational protein designs based on technology. In 2021, the rational protein design category held the largest market share. The rising use and continual improvements of bioinformatics platforms and software for protein analysis are credited to the substantial proportion of this market. Furthermore, the rational design segment is anticipated to be used as a result of the development of modeling tools and the fast-expanding quantity of 3D structures in databases. Moreover, protein remodeling is one of the most important applications of rational design, and it is a key contributor to rational design’s dominance in the protein engineering market.
By End-Use
The protein engineering market is divided into three segments based on end-user biopharmaceutical firms, contract research organizations, and university research institutes. In 2021, the biopharmaceutical firms category held the greatest market share. Protein engineering products are frequently employed by biopharmaceutical firms for drug discovery and development, since they aid in the construction of models for a wide range of protein-based medications. Furthermore, supportive groups provide financing to large pharmaceutical and biotechnology businesses to create next-generation treatments, resulting in increased use of engineering tools by these corporations. Hence, the aforementioned factors are expected to be accountable for the segment’s leading share.
By Region
North America will have a significant market share in 2021 in the protein engineering market. Constant cooperation, encouraged by leading market participants to improve their research and development capabilities, is thought to be responsible for this region’s higher share. Furthermore, prominent pharmaceutical businesses in this region are heavily involved in the marketing of new engineering techniques and the promotion of their use in research. Strategic initiatives by leading companies in the United States are a crucial element driving the regional market growth. Tierra Biosciences, for example, introduced the Tierra Protein Platform in February 2022, an industry-first eCommerce platform that enables clients to have unique proteins verified, produced, and sent to them. This platform offers a more convenient and quicker approach than traditional techniques for acquiring thousands of proteins for research and development.
Protein Engineering Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Protein Type launches have accelerated the growth of the Sample Preparation market. Key players in the market include-
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Agilent Technologies, Inc.
- Waters Corporation
- Danaher Corporation
- Codexis, Inc.
- New England Biolabs, Inc.
- PerkinElmer
- Innovagen AB
- GE Healthcare
- CUSABIO TECHNOLOGY LLC
- Promega Corporation
- Merck KGaA
- GenScript Biotech Corporation
- Takara Bio, Inc.
- Enantis S.R.O.
- InvivoGen
- Pace Analytical
- Aspira Chemical
- Zymeworks, Inc.
- Abzena, Ltd.
- PhyNexus, Inc.
- ProteoGenix
- Creative Biolabs
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Cancer Immunotherapy
- Global Protein Engineering Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Protein Engineering Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Cancer Immunotherapy demand
- Post-Covid Impact on Protein Engineering Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Protein Engineering Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Product and Service
- Instruments
- Consumables
- Software & Services
- By Technology
- Rational Protein Design
- Irrational Protein Design
- By Protein Type
- Monoclonal Antibodies
- Erythropoietin
- Interferons
- Vaccines
- Colony-stimulating Factors
- Growth Hormones
- Coagulation Factors
- Other
- By End Use
- Biopharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
- By Product and Service
- Global Protein Engineering Market Overview, By Region
- North America Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Product and Service
- By Technology
- By Protein Type
- By End Use
- Canada
- Mexico
- US
- Europe Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Protein Engineering Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Protein Engineering Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Bio-Rad Laboratories, Inc.
- Business Overview
- Business Financials (USD Million)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Agilent Technologies, Inc.
- Waters Corporation
- Danaher Corporation
- Codexis, Inc.
- New England Biolabs, Inc.
- PerkinElmer
- Innovagen AB
- GE Healthcare
- CUSABIO TECHNOLOGY LLC
- Promega Corporation
- Merck KGaA
- GenScript Biotech Corporation
- Takara Bio, Inc.
- Enantis S.R.O.
- InvivoGen
- Pace Analytical
- Aspira Chemical
- Zymeworks, Inc.
- Abzena, Ltd.
- PhyNexus, Inc.
- ProteoGenix
- Creative Biolabs
- Bio-Rad Laboratories, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.